Application and Optimization of Reverse Transcription Loop-Mediated Isothermal Amplification Assay for Rapid SARS-CoV-2 Detection in Humans and Animals
Authors:
Open Access
- 4 November 2024
- journal article
- Published by Egyptian Knowledge Bank in Egyptian Journal of Veterinary Sciences
- p. 1-16
Abstract
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) requires quick and dependable diagnostic solutions. Our study aimed to optimize the rapid detection of SARS-CoV-2 using the reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay and to compare its performance with the reverse transcription real-time TaqMan quantitative polymerase chain reaction (RT-qPCR) of RNA extraction protocols. Nasopharyngeal swabs (NPS), oropharyngeal swabs (OPS), mixed nasopharyngeal and saliva samples, and sputum samples from individuals with or without COVID-19 symptoms (outpatient n = 180, inpatient n = 50) were collected and stored at -80 °C. These samples were tested using RT-qPCR, RT-LAMP, and RT-PCR for comparison. Additionally, animal samples were tested, including cattle (n = 20), buffaloes (n = 10), sheep (n = 25), goats (n = 30), horses (n = 5), donkeys (n = 5), mules (n = 3), camels (n = 5), dogs (n = 10), cats (n = 5), and rabbits (n = 6). The detection rates of RT-qPCR were 7.3 ± 0.56, 8.0 ± 0.98, and 5.0 ± 0.56 for nasopharyngeal swabs (NPS), oropharyngeal swabs (OPS), and mixed nasopharyngeal and saliva samples mixed with sputum samples from outpatients (n = 180), respectively. For inpatients (n = 50), the means and SD were 43 ± 0.264, 43 ± 0.245, and 26 ± 0.376, respectively. The sensitivity of RT-LAMP was comparable to RT-qPCR, with 88.9% for outpatients and 99.4% for inpatients. Both assays demonstrated 100% specificity in both groups. The findings demonstrated the direct RT-qPCR assay, both with and without RNA extraction, produced positive resultsKeywords
This publication has 37 references indexed in Scilit:
- Performance of electrochemical immunoassays for clinical diagnostics of SARS-CoV-2 based on selective nucleocapsid N protein detection: Boron-doped diamond, gold and glassy carbon evaluationBiosensors and Bioelectronics, 2022
- A mass spectrometry-based targeted assay for detection of SARS-CoV-2 antigen from clinical specimensEBioMedicine, 2021
- Bats, pangolins, minks and other animals - villains or victims of SARS-CoV-2?Veterinary Research Communications, 2021
- Development of a database for the rapid and accurate routine identification of Achromobacter species by matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry (MALDI-TOF MS)Clinical Microbiology and Infection, 2021
- Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targetingEuropean Journal of Pharmacology, 2020
- Acute pulmonary embolism mimicking COVID – 19 pneumoniaInternational Journal of Infectious Diseases, 2020
- Understanding evolution of SARS‐CoV‐2: A perspective from analysis of genetic diversity of RdRp geneJournal of Medical Virology, 2020
- Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in SingaporeJAMA, 2020
- Laboratory biosafety for handling emerging virusesAsian Pacific Journal of Tropical Biomedicine, 2017
- Quantification of GPCR mRNA Using Real-Time RT-PCR2011